【上交所】湖北济川药业股份有限公司2024年第一季度报告

证券代码：600566证券简称：济川药业湖北济川药业股份有限公司2024年第一季度报告本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或重要内容提示公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息一、主要财务数据2,402,545,954.32845,266,461.6624.90726,257,023.961,338,802,553.072.8624.9024.76变动幅度(%)19,361,405,368.1618,143,694,578.5214,194,467,077.8913,349,441,189.41-61,902.92符合国家政策规定、按照确定的标准享有、对公司损益产生持业持有金融资产和金融负债产生的公允价值变动损益以及处置30,976,871.90942,753.6721,028,717.70定为的非经常性损益项目且金额重大的，以及将《公开发行证券的公司信息披露解释性公二、股东信息(一)普通股股东总数和表决权恢复的优先0份数量0无0无0无00-中欧医疗健康混合型证券000-中证500交易型开放式指00-中欧医疗健康混合型证券-中证500交易型开放式指公司前十名股东中，济川控股、西藏济川、曹龙祥为一人。其他股东与公司控股股东、实际控制人不存在关联关系、一致行动人的情况，公司未知上述其他股东之间是否存在关联关计-中证500量-中证500交金三、其他提醒事项需提醒投资者关注的关于公司报告期经营情四、季度财务报表合并资产负债表日7,737,982,810.083,178,269,912.5446,303,867.352,726,519,334.508,789,389.1625,616,914.08490,078,167.246,879,370.0414,235,429,851.57405,767,928.10393,971,897.605,733,879.885,895,065.702,669,473,820.182,732,099,754.66210,776,749.623,062,900.173,394,786.26300,016,790.76305,005,924.3034,209,666.5045,446,473.1357,067,916.7756,261,531.753,864,261,093.233,908,264,726.9519,361,405,368.1618,143,694,578.521,636,155,724.121,043,077,468.32439,121,874.92446,318,006.901,663,229,842.231,694,456,409.3478,600,095.14201,703,932.56279,746,997.74866,747,290.47908,510,221.795,252,280.005,252,280.0057,202,543.0547,095,242.014,961,751,163.604,591,861,830.43807,850.51819,850.5169,940,415.1971,433,328.355,145,996,129.574,774,832,070.86452,735,749.00452,735,749.004,005,833,558.923,999,077,702.229,693,042,464.628,847,776,002.9614,194,467,077.8913,349,441,189.4120,942,160.7014,215,409,238.5913,368,862,507.6619,361,405,368.1618,143,694,578.52公司负责人：曹龙祥主管会计工作负责人：严宏泉会计机构负责人：合并利润表2,402,545,954.322,388,296,884.092,402,545,954.322,388,296,884.091,594,276,317.541,706,503,386.50429,362,869.4038,740,096.8136,128,383.23989,645,386.931,089,196,034.0191,736,719.0483,875,694.91-93,766,374.59-38,688,417.887,550,518.452,929,452.0441,837,680.665,202,341.014,656,714.0527,925,994.86益20,976,297.6341,482,263.7824,890,965.50-5,944.0193,330.43885,925,169.46760,336,800.0630,505,387.22989,790,164.22789,506,839.15846,787,304.11678,157,318.97846,787,304.11678,157,318.971.归属于母公司股东的净利润（净亏损以“-”845,266,461.66676,756,832.78额846,787,304.11678,157,318.97845,266,461.66676,756,832.78本期发生同一控制下企业合并的，被合并方在合并前实现的净利润为：0元，公司负责人：曹龙祥主管会计工作负责人：严宏泉会计机构负责人合并现金流量表3,426,353,538.373,260,996,211.84279,960,858.833,706,314,397.203,396,627,119.54414,733,867.51328,063,792.39311,405,011.86294,219,943.05506,019,494.24481,292,588.771,135,353,470.52991,526,362.302,367,511,844.132,095,102,686.511,338,802,553.071,301,524,433.032,103,082,500.002,118,896,311.81购建固定资产、无形资产和其他长期资产支付86,347,903.79369,000,000.00455,347,903.791,663,548,408.02667,379,03